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Abstract: Campylobacter enteritis in humans is primarily associated with C. jejuni/coli infection.
Other species cause campylobacteriosis relatively infrequently; while this could be attributed to bias
in diagnostic methods, the pathogenicity of non-jejuni/coli Campylobacter spp. such as C. upsaliensis and
C. helveticus (isolated from dogs and cats) is uncertain. Galleria mellonella larvae are suitable models
of the mammalian innate immune system and have been applied to C. jejuni studies. This study
compared the pathogenicity of C. jejuni, C. upsaliensis, and C. helveticus isolates. Larvae inoculated
with either C. upsaliensis or C. helveticus showed significantly higher survival than those inoculated
with C. jejuni. All three Campylobacter species induced indistinguishable histopathological changes
in the larvae. C. jejuni could be isolated from inoculated larvae up to eight days post-inoculation
whereas C. upsaliensis and C. helveticus could only be isolated in the first two days. There was a
significant variation in the hazard rate between batches of larvae, in Campylobacter strains, and in
biological replicates as random effects, and in species and bacterial dose as fixed effects. The Galleria
model is applicable to other Campylobacter spp. as well as C. jejuni, but may be subject to significant
variation with all Campylobacter species. While C. upsaliensis and C. helveticus cannot be considered
non-pathogenic, they are significantly less pathogenic than C. jejuni.
Keywords: Galleria mellonella; pathogenicity; virulence; Campylobacter; dose response; emerging
pathogens; survival
1. Introduction
Campylobacteriosis is one the most common bacterial gastrointestinal diseases in people worldwide
and has mostly been associated with C. jejuni and C. coli infection [1]. The disease is predominantly
foodborne, especially through contaminated poultry meat, but as Campylobacter spp. is commonly
isolated from the intestinal tract of many animals, direct contact with animals and with contaminated
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water and environments are also important transmission routes of infection [1]. Diagnostic methods are
commonly optimised for the detection of C. jejuni/coli; hence, many other Campylobacter spp. species are
considered as under-reported, although they are implicated as human pathogens, and are often referred
to as ‘emerging’ pathogens [2,3]. C. upsaliensis and C. helveticus are the most common Campylobacter
spp. reported in dogs and cats, where they are frequently detected with considerable prevalence rates
that reach up to 63% [3,4], whereas they are rarely reported, with low prevalence rates (~1–2%) in
other sources [5–9]. C. upsaliensis is one of the leading emerging Campylobacter pathogens, as several
studies worldwide have reported higher isolation rates from human campylobacteriosis cases than the
rate of C. coli when suitable culture methods are applied [10]. Conversely, no or few occurrences have
also been reported with suitable methods [11–13] which could be affected by geographical, seasonal
and environmental exposure differences between study populations. C. helveticus closely resembles
C. upsaliensis [14] but has only been reported in one human study previously [15]. Considering that
the two species are common in pet animals but infrequent and disparate in humans, their pathogenic
potential remains uncertain.
Mechanisms of pathogenesis of Campylobacter spp. can be investigated by various approaches
such as in vivo research using “complete” or “partial” animal models of disease that reproduce
intestinal disease in many or only a few aspects of pathogenesis and virulence (primates, rodents,
chickens, etc.), or ex vivo approaches such as eukaryotic cell cultures, and molecular biology tools
which are necessarily “partial” models of disease because only particular aspects of disease stages
(e.g., colonisation, adhesion, invasion, toxigenesis, or roles of genes using mutant construction) can
be evaluated [16]. Invertebrates may also be used as an infection model due to a high degree of
functional and structural homology with the mammalian innate immune system [17]. The larvae of
the greater wax moth, Galleria mellonella, have been described as a model for many bacterial pathogens,
including species of Acinetobacter, Escherichia, Enterococcus, and Pseudomonas [18,19]. Larvae were
also described as an infection model for C. jejuni for the evaluation of the role of selected genes
in the mortality of larvae [20]. In that study, mutant strains of C. jejuni lacking defined virulence
factors showed an increased survival of larvae compared to the respective wild types. Subsequently,
the histological changes and survival of C. jejuni in the larvae were described and used to evaluate
differences in virulence between genotypes of C. jejuni according to the multi-locus sequence-typing
scheme [21]. That study showed extensive histological changes in larvae upon inoculation of C. jejuni,
and intracellular survival of C. jejuni within larval haemocytes.
The aim of this study was to use Galleria mellonella larvae as an infection model for the comparison
of the pathogenic potential between Campylobacter species. C. upsaliensis and C. helveticus were selected
as the emerging pathogens to which humans are likely to be frequently exposed from contact with
pets and were compared to the established pathogen C. jejuni. The survival of larvae inoculated with
viable bacteria and temperature-inactivated cells and cellular components, histopathological changes,
cultures of larval haemolymph and haemocytes, and dose-dependent survival analyses were used as
comparative features of larval infection between Campylobacter species.
2. Results
The Kaplan–Meier survival curves for larvae showed a clear dose-dependent survival for all
Campylobacter spp. (Figure 1).
With low bacterial doses, there were too few deaths recorded which precluded comparison of any
of the treatment groups. With medium doses, the survival of C. jejuni-inoculated larvae was significantly
lower than that of both C. upsaliensis- or C. helveticus-inoculated larvae (p < 0.001), the latter two not
being significantly different to each other. In contrast, with high doses, the survival of larvae was
significantly different between all Campylobacter spp. (p < 0.001). The survival of control groups showed
no difference with low bacterial doses of any Campylobacter spp.-inoculated larvae. The uninfected
larvae and larvae infected with low Campylobacter doses never exhibited macroscopic melanisation,
although reduced responses to physical stimuli were observed in the infected larvae only. Signs of
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morbidity in infected larvae with medium and high doses were always present. With the medium
bacterial dose, only the survival of C. jejuni-inoculated larvae was significantly different from that of
the control groups (p < 0.001), whereas with the high bacterial dose all Campylobacter spp.-inoculated
larvae had a significantly different survival from the control groups (p < 0.001). The survival of
phosphate-buffered saline (PBS)-inoculated and undisturbed larvae was not significantly different.
The results of the assays using temperature-inactivated bacteria or cellular components and different
incubating conditions are available in the Supplementary Materials.Pathogens 2020, 9, x 3 of 16 
 
 
Figure 1. Kaplan–Meier survival curves of 4273 larvae inoculated with three loads (~104, 106, and 108 
CFU/mL) of Campylobacter spp. and of control (280 each of phosphate-buffered saline (PBS)-inoculated 
and undisturbed) larvae groups. The survival curves are a summation of 34 strains of C. jejuni, 22 
strains of C. upsaliensis, and 13 strains of C. helveticus with each bacterial strain tested with two to four 
biological replicates and each tested in technical duplicates of sets of 10–15 larvae. In the low load 
only 12 strains of both C. jejuni and C. upsaliensis, and 10 strains of C. helveticus were evaluated. There 
were 1861 larvae used with high loads (821 C. jejuni, 630 C. upsaliensis and 410 C. helveticus larvae), 
1802 with medium loads (785 C. jejuni, 625 C. upsaliensis and 392 C. helveticus larvae), and 610 with 
low loads (225 C. jejuni, 205 C. upsaliensis and 180 C. helveticus larvae).The control larvae groups of the 
same experimental run are applicable to all loads prepared, but are shown only in one subplot for 
clarity. All assays were performed in a H2-enriched microaerobic atmosphere (H2-MA; 82% N2, 10% 
CO2, 5% H2, 3% O2) at 37 °C. 
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Figure 1. Kaplan–Meier survival curves of 4273 larvae inoculated with three loads (~104, 106,
and 108 CFU/mL) of Campylobacter spp. and of control (280 each of phosphate-buffered saline
(PBS)-inoculated and undisturbed) larvae groups. The survival curves are a summation of 34 strains
of C. jejuni, 22 strains of C. upsaliensis, and 13 strains of C. helveticus with each bacterial strain tested
with two to four biological replicates a d each tested in technical duplicates of sets of 10–15 larvae.
In the low load nly 12 strains of both C. jejuni and C. upsaliensis, and 10 strains of C. helveticus were
evaluated. There were 1861 larvae used with high loads (821 C. jejuni, 630 C. upsaliensis and 410 C.
helveticus larvae), 1802 with medium loads (785 C. jejuni, 625 C. upsaliensis and 392 C. h lveticus larvae),
and 610 with low loads (225 . jejuni, 205 C. upsaliensis and 180 C. helveticus larvae).The control larvae
groups of the same experimental run are applic ble to all loads prepared, but are show only in one
subplot for clarity. All assays were performed in a H2-enriched microaerobic atmosphere (H2-MA;
82% N2, 10% CO2, 5% H2, 3% O2) at 37 ◦C.
A summary of the hist pathological scores of infected and uninfected larvae is presented in Table 1.
The gut tissues in both infected and uninfected larvae could not be evaluated due to heavy utolysis.
Overall, the scores of fat bodies and haemolymph between infected and uninfected larvae were similar,
but the t o features showed l rge variatio s between larvae from the same experimental runs, and thus
were not statistically analysed. The scor s of haemoc tes w re not significantly different between the
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infected and uninfected larvae and between Campylobacter spp. within infected larvae. However, only
the infected larvae exhibited pigmentation in haemocytes’ cytoplasm and pigment deposition in tissues
(fat bodies, muscle, epithelial cells, haemolymph and gut lumen) and nodules (Figures 2–5). The overall
pigment scores were significantly higher in infected than in uninfected larvae (p < 0.01) but showed no
difference between Campylobacter spp. within the infected larvae. The pigment scores in haemocytes,
nodules and tissues between Campylobacter spp. within infected larvae were not significantly different.
Nodules were only observed in the infected larvae but with no difference between Campylobacter
spp. within infected larvae. Coccoid bacteria were almost always observed in infected larvae, but
filamentous rods and cocci were also noted, though infrequently, in both infected and uninfected larvae.
Scores for the abundance of bacteria were significantly higher in the infected than in the uninfected
larvae (p < 0.001) but not between Campylobacter spp. within the infected larvae. Within the infected
larvae, bacterial scores had a significant positive correlation with nodule scores (rho = 0.45, p < 0.01)
and pigment scores (rho = 0.41, p = 0.01). Similarly, bacterial scores had a significant positive correlation
(rho = 0.36, p = 0.04) with bacterial doses of inocula in infected larvae.
Table 1. Distribution of histopathology scores * in larvae infected with Campylobacter spp. and the
uninfected control larvae groups.
Feature Score C. jejuni(n = 11)
C. upsaliensis
(n = 10)
C. helveticus
(n = 12)
PBS-Inoculated
(n = 3)
Undisturbed Larvae
(n = 3)
Fat body
1 4 0 1 0 0
2 3 7 3 0 1
3 4 3 8 3 2
Haemolymph
1 3 5 8 1 0
2 7 5 4 2 3
3 1 0 0 0 0
Haemocytes
1 2 5 3 0 0
2 6 3 7 3 3
3 3 2 2 0 0
Nodules
0 1 3 3 3 3
1 6 3 5 0 0
2 4 4 4 0 0
Pigment
0 2 2 3 3 3
1 5 2 0 0 0
2 3 2 5 0 0
3 1 4 4 0 0
Bacteria
0 2 3 2 2 1
1 6 6 9 1 2
2 2 1 1 0 0
* Haemocytes were scored as one (low number of individual cells), two (low to moderate number of clusters) and
three (numerous clusters/sheets), and haemolymph and fat bodies as one (fat body taking ≤ 25% of cross-sections),
two (~50% of sections) and three (≥ 75% of sections). Pigment was scored as zero (no pigmentation), one (faint
pigmentation at 4×magnification), two (moderate pigmentation at 1.25×magnification) and three (obvious dark
pigmentation at 1.25×magnification). Nodules as aggregations of pigmented haemocytes were scored as zero (none),
one (few/section) and two (over 10/section). Bacteria were scored as zero (none), one (<25% filling of gut lumen)
and two (>25% of gut lumen) in gut tissue and as presence/absence in haemolymph. The scoring of bacteria was
unsuccessful in one run of C. jejuni-inoculated larvae.
The isolation of Campylobacter spp. from the haemolymph and haemocytes of larvae was attempted
on days one, two, three, five and eight post-inoculation. The isolation was successful with all of the
Campylobacter spp. from the haemolymph and from the haemocytes only with C. jejuni but never
from uninfected control larvae. The isolation of C. upsaliensis and C. helveticus from the haemolymph
was only successful in the first two days post-inoculation while C. jejuni was successfully isolated,
including from the haemocytes, up to eight days post-inoculation.
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Figure 2. Haematoxylin and eosin stained cross section of Galleria mellonella larva inoculated with 
Campylobacter helveticus that was observed dead on the second day of observation. Structures are 
identified as follows: fat bodies (f); haemolymph (h). Pigmented clusters of haemocytes are indicated 
by arrows. Bar = 1 mm. 
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Figure 2. Haematoxylin and eosin stained cross section of Galleria mellonella larva inoculated with
Campylobacter helveticus that was observed dead on the second day of observation. Structures are
identified as follows: fat bodies (f); haemolymph (h). Pigmented clusters of haemocytes are indicated
by arrows. Bar = 1 mm.
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Figure 3. Haematoxylin and eosin stained section of subcuticular region of Galleria mellonella larva,
inoculated with Campylobacter upsaliensis that was observed alive on the third day of observation
showing cuticle (arrowhead), fat bodies (f), and clusters of non-pigmented haemocytes. Bar = 25 µm.
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Figure 4. Haematoxylin and eosin stained section of Galleria mellonella larva inoculated with
Campylobacter upsaliensis that was observed dead on the second day of observation, showing densely
pigmented clusters (nodules) of haemocytes (arrows) within haemolymph (h) adjacent to fat bodies (f).
Other structures are indicated as follows: muscle (m); cuticle (c). Bar = 25 µm.Pathogens 2020, 9, x 7 of 16 
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replicates did not significantly contribute to the final model but were kept in order to quantify the 
Figure 5. Haematoxylin and eosin stained section of Galleria mellonella larva inoculated with phosphate-
buffered saline that was observed alive on the third day of observation showing bacteria within the
gastrointestinal tract lining the mucosal surface (right arrowhead) and free within the lumen (left
arrowhead). Bar = 25 µm.
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Cox proportional hazard (CoxPH) mixed effects regression analysis showed the larvae batch
shipment, and a nested structure of strain, bacterial dose, and biological and technical replicates were
significant random effects on the survival of larvae. The final model showed a significant variation
between species, as a fixed effect, with a hazard rate for C. upsaliensis and C. helveticus of 21% (95%CI
14–30%, p < 0.001) and 34% (95%CI 22–52%, p < 0.001) respectively, of the hazard rate of C. jejuni.
The hazard rate of C. upsaliensis was 61% (95%CI 39–95%, p = 0.03) of the hazard rate of C. helveticus.
An increase of one log unit from the average bacterial dose (~6.5 × 106 CFU/mL +/−3 × 105 standard
error of the mean) increased the hazard rate by 4.6 times (95%CI 4.1–5.2, p < 0.001) as an independent
fixed effect. The estimated standard deviation of the random effects was used to present the variability
within 95% of the population from the population average estimates. The final CoxPH model showed
the variation in the hazard rate of larval survival of batch shipments to be in the range of 61–165%
of the average batch estimate. For the nested structure of strains and replicates, the variation in the
hazard rate of bacterial strains was in the range of 81–141% of the average strain estimate, for biological
replicates it was in the range of 77–135% of the average biological replicate estimate, extending to
a 41–300% variation in the average estimate of bacterial dose used and, for the technical replicates,
to 95–107% of the average technical replicate estimate. Importantly, only the technical replicates did not
significantly contribute to the final model but were kept in order to quantify the effect of a commonly
employed experimental procedure. The mixed effects CoxPH model for control groups showed no
significant difference between the hazard rate of undisturbed and PBS-inoculated larvae. The random
effect of the batch shipments on the survival of control larvae groups ranged from 25 to 319%, and for
technical replicates it range from 76 to 146% of the average estimate.
3. Discussion
To be useful as a descriptor of pathogenic features, the survival/death of inoculated larvae must
be sufficiently contrasting between groups to allow differentiation. This differentiation is not possible
between groups inoculated with lower doses of Campylobacter; however, it is distinct when a higher
dose (108 CFU/mL) is used (Figure 1). The difference in survival curves between species in the larvae
model is suggestive of different pathogenicities, i.e., higher survival with lower pathogenicity and
vice versa. However, histopathological findings were not different between the Campylobacter species.
The histopathological findings in this study correlate well with the results of a study by Senior et al.,
investigating C. jejuni infection in larvae [21]. In that study, loss of integrity of the gut wall, activated
and apoptotic haemocytes, pigment and nodule formations (observed macroscopically as melanisation)
throughout the tissues and haemocoel were recorded in the infected larvae but not in the control larvae,
as in the present study. These consistent histological changes in Campylobacter spp.-inoculated larvae
and the clear differentiation from the changes in uninfected controls indicate that larvae as an infection
model are also suitable for C. upsaliensis and C. helveticus. The presumption that coccoid bacteria
observed in larval tissue sections are Campylobacter bacteria is supported by the successful isolation of
Campylobacter spp. from larval tissues and the significant positive correlation of the bacterial scores
with pigment and nodules scores and with the bacterial doses of the inocula used. The study by
Senior et al. [21] documented the survival of C. jejuni in larval haemocytes using green fluorescent
protein-tagged cells and found that the number of intracellular C. jejuni bacteria increases at 24 h
compared to 4 h post-inoculation, suggesting that C. jejuni can not only survive but also replicate in
larvae cells. This is in line with the results of haemolymph and haemocyte cultures of C. jejuni-inoculated
larvae being successful up to eight days post-inoculation in the present study. In contrast to the
histological findings, the present study showed many differences between Campylobacter spp. in the
survival of larvae, the critical importance of the evaluation of dose dependency for a comparison of the
three Campylobacter spp., and batches, strains of Campylobacter species, and biological and technical
replicates as sources of variability.
To use the survival of larvae as an endpoint for pathogenic features, the dose requires a sufficiently
different survival of larvae to allow a relative comparison with control larvae groups or other treatment
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group(s) [22]. The divergent survival of larvae inoculated with different Campylobacter spp. may not be
observable below a certain dose, yet may be observable for all species at higher doses and, depending
on the dose used, the difference from the survival of control larvae may vary (Figure 1). However,
the dose used must provide a sufficient distinction from control groups, as otherwise the experiment
would be deemed invalid. The mortality of control groups has no strict criteria, but, generally, it is
expected to be as low as possible and not more than 10–20%. This is in line with the results of the
CoxPH model, which showed no significant dose and species interaction, indicating that the effect of
dose is the same across the Campylobacter spp. examined. The dose-dependent survival of Galleria
mellonella larvae has been documented for many pathogens and differences can be as extreme as up
to several thousand-fold within species and within bacterial genera [19]. Several studies of C. jejuni
have reported strain-related variations in the survival of larvae. Excluding the data for mutant isolates,
the ranges in the survival of larvae were reported as 10–20% [23], 25–43% [20], and 3–36% [24] in studies
comparing less than five strains, and 50–100% in a study comparing 67 strains [21]. These studies were
matched by the dose used (which corresponds to the medium dose in this study), and all evaluated
the survival at 24 h except for Humphrey et al. [24], who evaluated larvae at 48 h post-inoculation.
The overall survival of larvae in this study is much higher than in previous studies, except for the study
by Senior et al. [21] for the corresponding time of observation and dose, which could be explained by,
but not limited to, different suppliers of larvae and the different bacterial strains used. This is further
supported by the findings of the significant random effects of batches, strains and biological replicates
in the current study, whose magnitudes show that independent experimental studies may return
similar survival rates despite a 100-fold difference in bacterial doses of the same strain, as well as a
disparate survival rate with the same dose and species/strain used. The small variation estimated for
the technical replicates and their insignificant contribution to the regression model show that consistent,
reproducible results were obtained within the experimental runs. This suggests that internal validity
for an observed difference is achievable in controlled experiments.
Galleria mellonella is a relatively new invertebrate model compared to Drosophila melanogaster,
or Caenorhabditis elegans, which have stock centres and community databases such as Flybase and
WormBase, respectively [25]. The lack of sources of genetically defined larvae strains and reference
populations, different breeding and maintenance practices between suppliers, and maintenance and
non-standardised experimental procedures between research laboratories, have been frequently raised
as limitations of experimental comparability [19,22,25]. Since, in this study, only one supplier was used,
the significant batch effect could be expected to be even larger for differences between suppliers than
within suppliers, which is a significant issue when comparing studies. The CoxPH model showed
some violations of the proportionality of the hazard rates, which caution us that the magnitude of the
estimates of species differences is not constant over the observation period. The violations were not
severe enough to invalidate the model, as no inverse relationships occurred, as shown by the fact that
there was no crossing of the Kaplan-Meier survival curves (Figure 1). However, this finding raises
questions about the choice of observation time for comparisons to be made. All of the previous studies
of C. jejuni in larvae with observations at 24 h had a 100% survival among control groups and survival
was over 98% at 48 h, the longest observation reported [24]. This is in line with the current study, as the
~10% mortality of control larvae groups was reached around the fifth day of observation and remained
constant until at least 10 days (Figure 1). This relatively low mortality rate of the control groups in the
present study shows that the observation period can be prolonged and that more information about
infection dynamics can be revealed in inoculated larvae.
The assays with altered environmental incubating conditions (see Supplementary Materials)
in this study showed improved survival for larvae infected with all Campylobacter spp. as the
conditions become less favourable for Campylobacter growth in vitro, with the control groups not being
adversely affected. A seminal study of Campylobacter in the larvae model reported the death of all
infected larvae at 25 ◦C and of control larvae at 42 ◦C but not at 37 ◦C, suggesting the model to be
suitable for mammalian but not avian gut temperatures; however, the exact atmospheric conditions of
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the larval experiments were not provided [20]. Multiple other studies used an incubation temperature
of 37 ◦C; however, only one reported atmospheric conditions (in that study, room temperature and an
aerobic atmosphere were used) [20,21,26–30]. This study showed that an H2-enriched microaerobic
atmosphere (H2-MA), which more closely mimics gut conditions than an aerobic environment, is
also suitable for the Galleria model and indicates that H2-requiring Campylobacter spp. of clinical
importance [3] could be tested as well. However, while the extent of changes inside the larvae
due to the outside environment was not evaluated herein, more importantly, due to the survival
of infected larvae being affected by the incubation atmospheric conditions, we recommend their
inclusion in the methods of future studies as an important variable. The influence of environmental
variables on the immune responses of larvae and the resulting limitations of their use as an animal
model is still largely unknown. Thus, the increased survival of Campylobacter spp.-inoculated larvae
incubated in decreasingly favourable incubating conditions for Campylobacter spp. could be due to
an altered immune response on the host side, decreased numbers of viable bacteria in the larvae,
or environment-induced changes in metabolic/virulence capacities of Campylobacter and should be
investigated further to understand the infection dynamics in the larvae model. Similarly, the results
of assays with inactivated bacteria indicate that more detailed studies of cellular components would
be beneficial to evaluate their role in the morbidity/mortality of larvae. Melanisation of larvae in
these assays was evident, which is a sign of the activation of the immune system that may also cause
substantial damage to the host and lead to death [31]. Interestingly, the survival of larvae inoculated
with inactivated bacteria was not different between Campylobacter spp. in contrast to survival following
inoculation with viable bacteria. This pattern suggests that the metabolic activity of viable C. upsaliensis
and C. helveticus cells contributes less to the death of larvae compared to their cell components than the
activity of C. jejuni cells does.
Insect haemocytes recognise pathogens and phagocytise foreign material in a similar manner to
mammalian neutrophils, with the killing of ingested microbes by both cell types by the production of
superoxide and by the release of enzymes in the process of degranulation [32]. While there are a variety
of cellular and humoral immune mechanisms that may also play a role in larvae [17], the survival of C.
jejuni in haemocytes is likely to be due to the possession of genes involved with oxidative and aerobic
stress tolerance. Studies have shown that the MarR-like transcriptional regulators, rrpA and rrpB,
are involved in the regulation of catalase (katA), alkyl hydroperoxide reductase (ahpC) and superoxide
dismutase (sodB) genes. These genes are involved in the tolerance of oxidative and aerobic stresses,
and mutants of these genes and their regulators were reported to be associated with the significantly
increased survival of larvae compared to the wild type isolate, a pattern not seen for mutants of
the peroxide-sensing regulator (perR), and rrpA and rrpB double mutants [33,34]. Phenotypically,
C. upsaliensis and C. helveticus are catalase weakly positive [35] and negative [14], respectively. However,
the higher survival of C. upsaliensis-inoculated than of C. helveticus-inoculated larvae in the present
study suggests that more than just catalase activity is needed to explain their survival.
This study demonstrates the larvae model as suitable for the investigation of the pathogenicity of
C. upsaliensis and C. helveticus by survival analyses, histopathological changes, and culture of larval
haemolymph and haemocytes. Their pathogenic potential was lower than that of C. jejuni, the major
pathogen of the genus. The lower pathogenicity of the former species is most likely attributable to the
faster clearance of the bacteria from haemolymph and their inability to survive in haemocytes in contrast
to C. jejuni. The survival of larvae was not significantly different between the three Campylobacter spp.
when inoculated with inactivated cells or cellular material, confirming the difference in pathogenic
potential being due to the metabolism of live, viable cells. Survival analyses also showed that longer
periods of observation are feasible in the larvae model and that a large variability in hazard rates exists
due to the effects of larvae batches, species strains, and biological but not technical replicates that
emphasise the limitations of comparisons between assays, yet confirm the internal validity within
experimental runs. Lastly, assays with different incubating conditions indicate that the larvae model
could be extended to H2-dependent Campylobacter and other similar bacterial species.
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4. Materials and Methods
4.1. Strains and Cultures
Overall, there were 34 strains of C. jejuni, 22 strains of C. upsaliensis, and 13 strains of C. helveticus.
Isolates of C. jejuni were selected to include frequent, common and rarely occurring sequence types
(STs) in humans from the mEpiLab collection, which contains over 3500 isolates from the Manawatu
Sentinel Site Surveillance project, a source attribution study using concurrent sampling of sick people,
animals, food and the environment [36]. C. upsaliensis and C. helveticus isolates were of unknown
genotypes and were selected from previous studies in dogs and cats [37,38], and other external sources.
As the main aim was species comparison, many strains were used in order to capture diversity at
the species level and exclude the potential bias of individual strains. Species type strains were also
included, and the details of all isolates are presented in Table 2.
Table 2. Details of Campylobacter species isolates used in the study.
C. jejuni Source MLST * Group
NCTC11351 Cattle ST-605/CC-43
ACP17c Dog ST-474/CC-48
ACP50a Cat ST-48/CC-48
ACP57b Dog ST-45/CC-45
ACP75a Dog ST-21/CC-21
ACP90c Dog ST-474/CC-48
ACP103c Dog ST-45/CC-45
ACP103d Dog ST-45/CC-45
ACP117c Cat ST-696/CC-1332
ACP176d Dog ST-474/CC-48
ACP191a Dog ST-61/CC-61
BD12f2b Dog ST-3676/CC-42
BD13d3a Dog ST-137/CC-45
H450 Human ST-61/CC-61
H550 Human ST-42/CC-42
H1763 Human ST-50/CC-21
H1792 Human ST-520/CC-21
H1796 Human ST-45/CC-45
H1799 Human ST-48/CC-48
H1804 Human ST-48/CC-48
H1849 Human ST-137/CC-45
H1878 Human ST-21/CC-21
H1884 Human ST-474/CC-48
H1910 Human ST-21/CC-21
H1924 Human ST-45/CC-45
H1969 Human ST-61/CC-61
H1972 Human ST-42/CC-42
H1978 Human ST-50/CC-21
H1987 Human ST-50/CC-21
H22082 Human ST-474/CC-48
P110b Poultry ST-474/CC-48
P525a Poultry ST-2381/NA
P836a Duck ST-3609/CC-48
P970a Duck ST-3961/NA
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Table 2. Cont.
C. jejuni Source MLST * Group
C. upsaliensis Source
ACP5b, ACP18a, ACP19b, ACP64a, ACP72b,
ACP144b, ACP136a, ACP149b, BD16e4a, ESR3675 Dogs
ACP9b, ACP135c, ACP170a, ACP170b, ACP179b Cats
LR128, LR129, LR130, LR131, LR132 Wildlife
ERL103233, ERL112092 Humans
C. helveticus Source
ACP102a, ACP105a, ACP105b, ACP108a, ACP110b,
ACP114b, ACP123b, ACP175a, ACP183a,
CCUG30563, CCUG30682, CCUG30683
Cats
ACP141a Dog
* Multi-locus sequence typing scheme: sequence type (ST)/clonal complex (CC).
Isolates were recovered from 15% (weight/volume) glycerol (#G/0650/17, Fisher Scientific,
Loughborough, UK) in nutrient broth (#CM0067, Oxoid, Basingstoke, UK) vials stored at −80 ◦C by
plating on Columbia horse blood agar (#1085, Fort Richard, Auckland, New Zealand) incubated in a
H2-MA (82% N2, 10% CO2, 5% H2, 3% O2) in an M85 variable atmosphere workstation (Don Whitley
Scientific, Bingley, UK) at 37 ◦C. Species identification was previously confirmed using PCR targeting
the hipO gene for C. jejuni [39] and the 16S rRNA gene for C. upsaliensis and C. helveticus [40].
4.2. Galleria Mellonella Assays
Fifth instar larvae were obtained from Biosuppliers (Auckland, New Zealand), kept (as delivered)
in a mixture of wood chips and honeycomb at room temperature, and used within four days.
Using manual restraint of the larvae, inocula of approximately 10 µL were injected into the haemocoel
via the last left proleg using 31G insulin syringes (#328822, Becton Dickinson Co., Holdredge, NE,
USA) on sets of 10–15 larvae. Upon inoculation, the larvae were kept in Petri dishes with a moist
tissue and no food. Larvae inoculated with phosphate-buffered saline pH 7.3 (PBS-inoculated) and
undisturbed larvae were used as controls for the experimental procedure and the incubating conditions,
respectively, and all assays were performed in technical duplicates. Larvae were observed daily for
up to 12 days with a minimum of five days of observation. The morbidity and mortality assessment
consisted of evaluation of colour changes (melanisation), righting reflex and responses to physical
stimuli. The absence of the righting reflex and responses to stimuli were considered signs of death
(mortality), while melanisation and either reduced responses to stimuli or the absence of the righting
reflex were considered as signs of morbidity. A subset of larvae was used to culture Campylobacter
spp. from haemolymph and evaluate whether Campylobacter was associated with haemocytes over
several days post inoculation. The whole larvae were ethanol (70% vol/vol) washed, flamed and
then the bottom ~2–3 mm of the body was aseptically removed and the haemocoel drained into a
sterile microcentrifuge tube and centrifuged at 200 g for 5 min. The haemolymph (supernatant) was
transferred to another tube, plated on blood and cefoperazone amphotericin teicoplanin (CAT) agars
(#1048, Fort Richard, Auckland, New Zealand) and cultured as above. The pelleted haemocytes were
resuspended in 1 mL sterile Milli-Q® water (Merck-Millipore, prepared in-house), pipetted up and
down ten times to lyse the cells and thereafter cultured as the haemolymph [21].
In total, 5878 larvae obtained from seven different batches were used for inoculation with C. jejuni
(2137 larvae), C. upsaliensis (1751), C. helveticus (1272), PBS (338), and Mueller–Hinton broth (10) (#3222,
Fort Richard, Auckland, New Zealand) while 385 served as undisturbed controls. The main focus was
the inoculation of larvae with viable bacteria using three 100-fold dilutions incubated in H2-MA at
37 ◦C. For the three different bacterial loads evaluated, there were 1861 larvae used with high loads
(821 C. jejuni, 630 C. upsaliensis and 410 C. helveticus larvae), 1802 with medium loads (785 C. jejuni,
625 C. upsaliensis and 392 C. helveticus larvae), and 610 with low loads (225 C. jejuni, 205 C. upsaliensis
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and 180 C. helveticus larvae). All bacterial strains in each experimental run were tested with high and
medium loads but not low loads. The low load was discontinued due to the insufficient mortality of
the larvae inoculated with bacteria compared with those of control groups; only 12 strains of both C.
jejuni and C. upsaliensis, and 10 strains of C. helveticus were tested with low loads. Each bacterial strain
was tested in two to four biological replicates, from which dilutions were made for the bacterial loads
with technical duplicates for each load. Both control larvae groups always had two technical duplicates.
The incubating conditions for these primary assays performed in an H2-MA at 37 ◦C were considered
an ‘optimal environment’ and a small subset of larvae was used for assays using the inactivated
bacteria or cellular material, and different incubation environments. The environment was categorized
in terms of its ability to support the growth of Campylobacter species. The use of room temperature
and H2-MA, or aerobic atmosphere and 37 ◦C was considered a ‘partial environment’, whereas the
use of room temperature and an aerobic environment was designated as an ‘adverse environment’.
The assays in different environments were performed to evaluate the dependencies on temperature
and atmosphere of Campylobacter bacteria to cause the infection and/or death of the larvae. Assays with
temperature-inactivated cells and cellular components were performed to evaluate their effect on the
survival of larvae. As these assays were not the primary aim of the study, the biological replicates
were not evaluated and only high loads with technical duplicates were tested using two to four strains
of each species. Assays with inactivated bacteria or cellular material were always performed in an
‘optimal environment’.
The heat-inactivation of bacteria was performed by heating the inocula at 100 ◦C for 10 min in sterile
microcentrifuge tubes placed in a heat block. The suspension of heat-killed bacteria was briefly vortexed
and used as a ‘whole-cell’ assay and an aliquot was transferred to a sterile microcentrifuge tube and
centrifuged at 12,000 g for 3 min. The supernatant was pipetted into a new sterile microcentrifuge tube,
briefly vortexed and used as a ‘heat-inactivated soluble’ assay, while the pelleted cellular material
was re-suspended in one mL of PBS, briefly vortexed and used as a ‘heat-inactivated insoluble’ assay.
The cold-inactivation of bacteria was performed by a triple freeze–thaw procedure between −80 ◦C
and 42 ◦C in three cycles of 30 min duration. The suspensions of cold-killed whole-cell and soluble
assays were performed as for the heat-killed assays. The ‘cold-inactivated insoluble’ assay was omitted
due to a visible inhomogeneity of samples that could not be improved by vortexing. For the heat-
and cold-inactivated assays the inactivation was checked by culturing as described above. For the
secretory products assay, bacteria were subcultured into 6 mL of Mueller–Hinton broth (Fort Richard,
Auckland, New Zealand) and incubated in H2-MA at 37 ◦C in airtight boxes at 200 rotations per minute
until turbid (usually two days for C. jejuni and C. upsaliensis and three to four days for C. helveticus).
The broth was centrifuged in the same way as for the heat-inactivation assay with the supernatant
pipetted into a sterile microcentrifuge tube and used as the ‘secretory products’ assay, while control
larvae were injected with sterile Mueller–Hinton broth.
4.3. Campylobacter Inocula
One-hundred and thirty-five inocula were prepared by suspending one to two whole agar
plates’ growth of Campylobacter spp. in PBS followed by one or two 100-fold dilutions in PBS. For
a quantification of bacterial concentrations, the inocula were serially diluted, spiral-plated (WASP,
Don Whitley Scientific, Bingley, UK) on blood agar and incubated as above. Bacterial colony counts
were performed manually and/or using an aCOLyte colony counter (Synbiosis, Cambridge, UK).
Subsequently, 18 inocula were adjusted to 0.05 light transmittance at 590 nm using a turbidimeter
(#3587, Biolog, Hayward, CA, USA) from which dilutions for the inoculation of larvae and the
quantification of bacterial concentration were performed. These estimates of bacterial concentration
were used for the subsequent 72 inocula with the turbidity adjusted accordingly because colony
counting was not performed further.
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4.4. Histopathology
A microscopic evaluation was performed on two to four larvae pooled from the same experimental
run from 11 experimental runs of C. jejuni, 10 of C. upsaliensis, 12 of C. helveticus, three of PBS-inoculated
larvae and three of undisturbed control larvae. Evaluations were made during the first three days
of the observation period except for one control and one C. jejuni run on the 10th day. Due to the
severe loss of tissue architecture in most longitudinal sections, only transverse sections were scored
and evaluated. There were, on average, 4.4 sections (2.0 standard deviation) per experimental run;
all were evaluated and scored. Larvae were placed in neutral-buffered 10% (vol/vol) formalin and
fixed for a minimum of two days. Longitudinal and transverse sections were processed routinely
into paraffin and 4-µm sections stained with haematoxylin and eosin. The abundance of haemocytes,
haemolymph, pigment, nodules, bacteria and adipose tissue (fat body) was scored semi-quantitatively
and the assessor was blinded to treatment groups. Haemocytes were scored as one (low number
of individual cells), two (low to moderate number of clusters) and three (numerous clusters/sheets),
and haemolymph and fat bodies as one (fat body taking ≤ 25% of cross-sections), two (~50% of sections)
and three (≥ 75% of sections). Pigment was scored as zero (no pigmentation), one (faint pigmentation
at 4×magnification), two (moderate pigmentation at 1.25×magnification) and three (obvious dark
pigmentation at 1.25×magnification). Nodules, as aggregations of pigmented haemocytes, were scored
as zero (none), one (few/section) and two (over 10/section). Bacteria were scored as zero (none),
one (< 25% filling of gut lumen) and two (> 25% of gut lumen) in gut tissue and as presence/absence
in haemolymph.
4.5. Statistical Analysis
Statistical and exploratory data analyses were performed using R v3.2.2 (R: A language and
environment for statistical computing, R Core Team (2013), R Foundation for Statistical Computing,
Vienna, Austria. URL: http://www.R-project.org/). An analysis of survival data was performed using
log-rank tests of Kaplan–Meier survival curves and Cox proportional hazards mixed regression models.
For modelling, the bacterial dose was log10 transformed, and its functional form was evaluated by
plotting model coefficients against a categorical transformation of the dose and by locally estimated
scatterplot smoothing (LOESS) regression of martingale residuals against the dose of models with and
without the dose included. With the assumptions being satisfied, the bacterial dose was centred to
the mean and used as a continuous covariate. Models were built using the forward step procedure
and selected based on ANOVA tests. Kruskal–Wallis non-parametric tests were used for the testing of
histopathology scores between the infected and uninfected larvae, and between Campylobacter spp.
within the infected larvae. Spearman’s rank correlation test was used for the testing of correlations
between ordered factors. All statistical analyses used a level of significance at α = 0.05.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/9/713/s1,
Figure S1: Kaplan–Meier survival curves of larvae inoculated with Campylobacter spp. (~108 CFU/mL) and control
(phosphate-buffered saline (PBS) inoculated and undisturbed) groups in optimal temperature and atmospheric,
and altered incubating conditions according to the suitability for in vitro isolation of Campylobacter species.
Figure S2. Kaplan–Meier survival curves of larvae inoculated with temperature-inactivated whole-cells and
secreted products of Campylobacter species.
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